FDA Matters logo
  • Blog
  • About
  • Media
The HHS RIF: Frequently-Asked Questions About FDA

The HHS RIF: Frequently-Asked Questions About FDA

by Steven Grossman | Mar 28, 2025 | Short Takes and Updates

Lots of media inquiries yesterday about the consequences of the HHS RIF announcement (Announcement, Fact Sheet). Here is what I told reporters:  “The FDA’s portion of the reduction in force is 3,500 and that would be in addition to those who took buyouts...
The HHS RIF: Frequently-Asked Questions About FDA

Three Historical Forces Clashing Over the Future of American Government

by Steven Grossman | Mar 25, 2025 | Short Takes and Updates

—A Follow-Up to “What’s Happening to FDA Employees: An Analogy Can Help”— This past Friday’s column–“What’s Happening to FDA Employees: An Analogy Can Help” (here)—was one of my most widely-read articles[1].  While the analogy helped many readers, the most...
The HHS RIF: Frequently-Asked Questions About FDA

What Is Happening to FDA Employees? An Analogy Can Help

by Steven Grossman | Mar 21, 2025 | Short Takes and Updates

I was out-of-town for part of the week and was asked several times: what is happening to Federal workers, especially those at FDA? By way of an answer, I created this analogy:  There is a bakery with ten employees. Because fresh baked goods will be...
The HHS RIF: Frequently-Asked Questions About FDA

The MAHA Challenge: Can It Lead to a Healthier and Safer Food Supply?

by Steven Grossman | Mar 18, 2025 | Short Takes and Updates

Let us agree at the outset that food policy and regulation is too important to be ignored. After all, every American ingests food multiple times each day. Nothing else is such a ubiquitous part of our lives. So, I am fully committed to the value of a major...
The HHS RIF: Frequently-Asked Questions About FDA

Short Takes and Updates—March 14, 2025

by Steven Grossman | Mar 14, 2025 | Short Takes and Updates

If you have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to sign up. 1. Zero-Based Defense (ZBD) of Critical Government Programs In the March 12 FDA Matters blog (here) I observed that incoming leaders during a...
The HHS RIF: Frequently-Asked Questions About FDA

What I Learned By Speaking About “FDA in Trump 2.0”

by Steven Grossman | Mar 12, 2025 | Short Takes and Updates

If you have not signed up to receive the FDA Matters newsletter in your email box, go to the home page to sign up. On Monday, I had the honor to address the annual meeting of America’s Blood Centers (ABC). It reminded me how much I learn by preparing for speeches and...
« Older Entries
Next Entries »

Recent Posts

  • The FDA’s Century-Long Campaign to Assure Safe Manufacturing (Part 2)
  • The FDA’s Century-Long Campaign to Assure Safe Drug Manufacturing (Part 1)
  • A Marathon, Not a Sprint: The Long Road to Becoming the Next FDA Commissioner
  • Firing Dr. Makary Solves No Problems….BUT Opens the Door for More Orderly Management and Decision-Making
  • Spotlight: The Partnership for Safe Medicines (PSM)

Recent Comments

No comments to show.
FDA Matters logo

 ©2009-2026 FDA Matters | FDA Matters does not report the news….we provide analysis of what’s behind the news.

We sometimes use artificial intelligence in drafting columns, primarily using Claude AI and Microsoft Co-Pilot. We review and verify all findings, interpretations, and final wording.